Compare PRAX & URBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRAX | URBN |
|---|---|---|
| Founded | 2015 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 6.0B |
| IPO Year | 2020 | 1995 |
| Metric | PRAX | URBN |
|---|---|---|
| Price | $305.51 | $77.69 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 12 |
| Target Price | ★ $572.13 | $86.91 |
| AVG Volume (30 Days) | 329.6K | ★ 1.0M |
| Earning Date | 05-08-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.78 |
| EPS | N/A | ★ 1.30 |
| Revenue | N/A | ★ $6,165,376,000.00 |
| Revenue This Year | N/A | $10.67 |
| Revenue Next Year | $7,758.26 | $7.01 |
| P/E Ratio | ★ N/A | $57.06 |
| Revenue Growth | N/A | ★ 11.07 |
| 52 Week Low | $37.25 | $59.54 |
| 52 Week High | $366.52 | $84.35 |
| Indicator | PRAX | URBN |
|---|---|---|
| Relative Strength Index (RSI) | 46.51 | 58.64 |
| Support Level | $284.87 | $66.70 |
| Resistance Level | $331.21 | $78.23 |
| Average True Range (ATR) | 16.88 | 2.66 |
| MACD | -2.16 | 0.44 |
| Stochastic Oscillator | 34.34 | 88.22 |
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.
Founded in 1970, Philadelphia-based Urban Outfitters is a multibrand apparel and home goods retailer that operates nearly 800 stores and e-commerce in the US, which accounts for about 87% of sales, as well as in other regions. Its retail nameplates are Urban Outfitters (22% of fiscal 2026 sales), Free People/Movement (26%), and Anthropologie (42%). Retail accounted for 86% of fiscal 2026 revenue, but Urban Outfitters also sells products through a wholesale operation, owns some restaurants, and operates a fast-growing clothing rental and resale business called Nuuly (9% of sales). Urban Outfitters primarily markets to young adults and offers products across apparel (66% of sales), home goods (16% of sales), accessories (13% of sales), and more.